Document is current
Any future updates will be listed below
-
Authors
Garofano, Luciano https://orcid.org/0000-0001-8582-0865
Migliozzi, Simona
Oh, Young Taek
D’Angelo, Fulvio https://orcid.org/0000-0002-4940-4693
Najac, Ryan D.
Ko, Aram
Frangaj, Brulinda
Caruso, Francesca Pia https://orcid.org/0000-0002-2206-1459
Yu, Kai
Yuan, Jinzhou
Zhao, Wenting
Di Stefano, Anna Luisa
Bielle, Franck
Jiang, Tao https://orcid.org/0000-0002-7008-6351
Sims, Peter
Suvà, Mario L.
Tang, Fuchou https://orcid.org/0000-0002-8625-7717
Su, Xiao-Dong
Ceccarelli, Michele https://orcid.org/0000-0002-4702-6617
Sanson, Marc
Lasorella, Anna https://orcid.org/0000-0002-1839-5421
Iavarone, Antonio https://orcid.org/0000-0002-0683-4634
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA101644)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (U54CA193313)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA131126)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA178546)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (U54CA193313)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA179044)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA190891)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA239698)
Associazione Italiana per la Ricerca sul Cancro (IG 2018 ID. 21846)
The Chemotherapy Foundation grant to A.I.
- License Information
-
More Information
Article History
Received: 10 June 2020
Accepted: 25 November 2020
First Online: 11 January 2021
Competing interests
: A.L. and A.I. are inventors of a biomarker technology that has been licensed to QIAGEN. A.I. received sponsored research funding from AstraZeneca and Taiho Pharmaceutical and has served as a paid consultant/advisor to AIMEDBIO Inc. A.L. received sponsored research funding from Celgene. All other authors declare no competing interests.
